Article Text

Download PDFPDF
Risk-Reducing Salpingectomy as Preventative Strategy for Pelvic Serous Cancer
  1. Charles K. Anderson, MD,
  2. Shannon Wallace, MD,
  3. Maryam Guiahi, MD,
  4. Jeanelle Sheeder, PhD,
  5. Kian Behbakht, MD and
  6. Monique A. Spillman, MD, PhD
  1. Division of Gynecologic Oncology, University of Colorado Health Sciences Center, Aurora, CO.
  1. Address correspondence and reprint requests to Charles Anderson, MD, Division of Gynecologic Oncology, University of Colorado Health Sciences Center, Campus Box B198-4, 12631 E 17th Ave, PO Box 6511, Aurora, CO 80045. E-mail: Charles.anderson{at}ucdenver.edu.

Abstract

Abstract The systemic failure to detect early-stage ovarian cancer may be attributed to a significant amount of pelvic serous cancers arising from the fallopian tube rather than the ovarian surface epithelium. This article reviews the possibility of applying risk-reducing salpingectomy as a new paradigm for the prevention of pelvic serous cancer in both high- and low-risk women.

  • Ovarian carcinoma
  • Salpingectomy
  • Risk reduction

Statistics from Altmetric.com

Footnotes

  • The authors declare no conflicts of interest.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.